Ares Capital 2025-26: $15.8B Record, Portfolio $29.5B, ROE 10%+

FY25 revenue $3.15B (+33%); op income $2.19B (+37%); NI $1.30B (-15% from FY24 elevated mark gains); EPS $1.86 (-24%). FCF $1.14B (-11%). Core EPS Q4 $0.50 / FY $2.01. Total new commitments 2025 reached $15.8B — new annual record. Portfolio at fair value ended Q4 at $29.5B, up from prior periods. Core EPS fully covered dividends and drove ROE in excess of 10% for both Q4 and full year. Rebound in transaction activity H2 2025 led to meaningful acceleration in new investment commitments. Specialized industry verticals (sports media, specialty healthcare, others) saw non-sponsored originations grow over 50%. Portfolio company performance: weighted average organic EBITDA growth over 3 times GDP; average portfolio leverage decreased; interest coverage ratio improved to 2.2 times. Credit quality remained stable with non-accruals in line with prior levels. Pretax net realized gains on investments over $100M in 2025. Total debt $15.99B (+16%). FY26 framework: expect ~$0.10/share earnings headwind from decline in base rates; Q1 2026 dividend $0.48/share payable March 31; strong start to 2026 with nearly $1.4B commitments through January 29, 2026; backlog $2.2B (17% greater than prior period); confidence in maintaining dividend with spillover income providing cushion.

Key takeaways

• $15.8B record total new commitments in 2025; backlog $2.2B (17% above prior) — multi-year direct lending franchise dominance. Ares Capital deployed a record $15.8B in new commitments in 2025, with backlog at $2.2B at year-end (+17% vs prior period). Q4 saw a meaningful acceleration in new investment commitments driven by H2 2025 rebound in transaction activity. Combined with $1.4B+ commitments through January 29, 2026 = strong start to FY26. The combination demonstrates the multi-year franchise dominance: ARCC is the largest BDC by AUM ($29.5B portfolio fair value) and has the deepest origination platform globally.

• Core EPS $2.01 FY25 / $0.50 Q4 fully covered dividends + drove ROE 10%+ — multi-year compounding intact. Core EPS of $0.50 in Q4 + $2.01 for FY25 fully covered the $1.92 annual dividend ($0.48/quarter) with positive coverage. ROE >10% in both Q4 and FY25 — durable compounding through cycles. The combination of (a) sustainable core earnings, (b) dividend coverage, (c) ROE >10% positions ARCC as one of the cleanest BDC compounders in the sector.

• Portfolio company organic EBITDA growth >3x GDP; leverage down; interest coverage 2.2x — credit quality robust. Portfolio company weighted average organic EBITDA growth was over 3 times GDP. Average portfolio leverage decreased; interest coverage ratio improved to 2.2x. Combined with credit quality remaining stable + non-accruals in line with prior levels + pretax net realized gains >$100M, the underlying credit health of the $29.5B portfolio is meaningfully positive — a reassuring signal in a year where some private credit peers reported elevated distress.

• Specialized industry verticals (sports media + specialty healthcare + others) +50% non-sponsored origination — multi-year niche franchise expansion. Specialized industry verticals saw non-sponsored origination growth +50%, a meaningful diversification from traditional sponsor-backed direct lending. Sports media + specialty healthcare + other verticals create higher-margin niche origination opportunities and are less sensitive to PE deal cycle dynamics. Multi-year franchise expansion thesis.

• FY26 base rate headwind ~$0.10/share offset by spillover income + commitment momentum — dividend confidence intact. Management explicitly guided to ~$0.10/share earnings headwind in 2026 from base rate decline. However, multiple offsetting factors maintain dividend confidence: (a) low balance sheet leverage providing flexibility, (b) incremental growth opportunities, (c) spillover income providing cushion (BDCs accumulate excess earnings to support dividends in cyclical years), (d) strong commitment momentum carrying forward. Q1 2026 dividend $0.48/share payable March 31 — maintained at $1.92 annualized.

Business

Ares Capital Corporation is the largest US Business Development Company (BDC) by net assets, with multi-strategy direct lending platform managed by Ares Management:

• Direct Lending (~95% of revenue): First-lien + second-lien + unitranche + mezzanine + structured equity. ~$29.5B portfolio fair value at Q4 FY25. ~80% senior debt; ~20% junior + equity. Multi-region US-focused.
• Specialized Industry Verticals (Embedded): Sports media + specialty healthcare + others. Non-sponsored origination +50% FY25.
• Senior Direct Lending Program (SDLP): Joint venture with Varagon for senior direct lending.

Strategic moves FY25:

• Total new commitments record $15.8B
• Portfolio at fair value $29.5B Q4 (up from prior periods)
• Core EPS Q4 $0.50 / FY $2.01 covering dividends
• ROE >10% Q4 + FY
• Specialized industry verticals non-sponsored +50%
• Portfolio organic EBITDA growth >3x GDP
• Interest coverage 2.2x (improved)
• Pretax net realized gains >$100M FY25
• Strong start FY26: $1.4B+ commitments through January 29
• FY26 backlog $2.2B (+17% vs prior)
• Q1 2026 dividend $0.48/share

FY25 financial performance

The earnings progression: revenue grew strongly $1.20B → $3.15B (FY22-25, +163% over 3 years) reflecting BDC AUM scaling + portfolio income + base rate environment. Op margin in 67-72% range — typical BDC structural margin. EPS GAAP $1.86 reflects mark-to-market + realized portfolio dynamics; Core EPS $2.01 is the cleaner economic measure.

Total debt $15.99B (+16% YoY) reflects portfolio expansion. Q1 2026 dividend $0.48/share announced ($1.92 annualized). FCF $1.14B (-11% YoY).

Capital allocation

• Capex: $0 (BDC structure).
• Dividends: Q1 2026 $0.48/share announced ($1.92 annualized). FY24 $1.139B paid; FY25 dividend payments via standard BDC schedule.
• Buybacks: $0 (no buyback; capital deployed to portfolio).
• Total debt: $15.99B (+16% YoY).
• FCF: $1.14B FY25.
• Spillover income: Provides cushion for FY26 dividend.

FY26 outlook (per Q4 2025 call, 2026-02-04)

Management noted continued multi-year direct lending platform leadership + specialized verticals + non-sponsored origination + strong start to 2026.

Key risks

Base rate environment. ARCC core earnings highly correlated with SOFR / base rate environment. ~$0.10 FY26 EPS headwind from rate decline already guided.

Credit cycle dynamics. Multi-year private credit cycle + non-accrual rates + reserve adequacy + recovery rates all matter.

Direct lending competitive landscape. Apollo, Blackstone, KKR, Blue Owl, Golub, Antares, Audax, Ares competitors all compete for deals. Multi-year competitive intensity.

Sponsor PE deal cycle. Multi-year LBO + PE M&A cycle drives sponsor-backed direct lending demand. H2 2025 rebound positive but multi-quarter cyclicality.

Portfolio company concentration. Multi-tenant portfolio but some concentration risk in larger holdings.

Spread compression. Multi-year private credit spread compression as more capital chases deals.

Mark-to-market volatility. Multi-quarter portfolio mark-to-market fluctuations affect GAAP NI + book value.

Regulatory environment. SEC + BDC regulations + leverage limits + diversification requirements all matter.

Refinancing dynamics. Portfolio company refinancings + ARCC's own debt refinancing.

Origination platform execution. Multi-year sourcing + underwriting + monitoring platform execution.

Non-sponsored origination dynamics. Specialized verticals require multi-year team building + relationships.

SDLP partnership dynamics. Varagon JV dynamics + economics over multi-year horizon.

External management dynamics. Externally managed BDC with Ares Management as advisor; advisor incentive alignment + fee structure dynamics.

Capital raising timing. Multi-quarter ATM + secondary offerings + timing affects per-share dynamics.

Dividend coverage sustainability. $1.92 annualized requires continued core earnings; spillover income cushion finite.

Bottom line

Ares Capital FY25 is the multi-year direct lending franchise dominance + record commitments + portfolio quality year: revenue $3.15B (+33%); op income $2.19B (+37%); NI $1.30B (-15% on lower mark gains); EPS $1.86; Core EPS $2.01. Total new commitments record $15.8B. Portfolio at fair value $29.5B. Core EPS fully covered dividends; ROE >10% Q4 + FY. Specialized verticals non-sponsored +50%. Portfolio organic EBITDA growth >3x GDP; interest coverage 2.2x improved. Credit quality stable; non-accruals in line; pretax net realized gains >$100M. Strong start FY26: $1.4B+ commitments YTD through Jan 29; backlog $2.2B (+17% vs prior). Total debt $15.99B (+16%).

FY26 framework: ~$0.10/share earnings headwind from base rate decline; Q1 2026 dividend $0.48/share; spillover income provides dividend cushion; ROE 10%+ multi-year track record continues.

The risks are real — base rate environment, credit cycle dynamics, direct lending competitive landscape (Apollo, Blackstone, KKR, Blue Owl, Golub, Antares, Audax), sponsor PE deal cycle, portfolio company concentration, spread compression, mark-to-market volatility, regulatory environment (BDC), refinancing dynamics, origination platform execution, non-sponsored origination dynamics, SDLP partnership dynamics, external management dynamics, capital raising timing, dividend coverage sustainability.

But the structural thesis (largest US BDC by net assets + Ares Management externally managed advantage + portfolio fair value $29.5B + record FY25 new commitments $15.8B + strong FY26 start ($1.4B+ commitments + $2.2B backlog +17%) + Core EPS $2.01 covering dividend + ROE 10%+ both Q4 + FY + portfolio company organic EBITDA growth >3x GDP + interest coverage 2.2x improved + specialized industry verticals non-sponsored +50% + multi-year direct lending franchise dominance + spillover income dividend cushion) is intact and FY25 confirms.

Quality US direct lending BDC compounder mid-cycle, with multi-year franchise dominance + Ares Management platform + portfolio quality + diversified specialized verticals + spillover income + dividend stability + credit quality + ROE 10%+ track record. The FY25 record $15.8B commitments + $29.5B portfolio + Core EPS $2.01 + ROE 10%+ + portfolio organic EBITDA >3x GDP + interest coverage 2.2x + strong FY26 start + Q1 2026 dividend $0.48/share creates one of the cleaner direct lending BDC compounding setups for investors seeking exposure to private credit + dividend yield + ROE 10%+ + Ares Management platform. The conservative FY26 framework + $0.10 rate headwind offset by spillover + multi-year track record + commitment momentum + specialized verticals provides multiple paths to outperformance over a multi-year horizon. Base rates + credit cycle + competition + spread compression + sponsor cycle remain ongoing risks, but the franchise dominance + portfolio quality + dividend coverage + multi-year ROE support continued compounding through cycles.

Citations

• Ares Capital Corporation FY25 Form 10-K (filed February 2026, SEC EDGAR).
• ARCC Q4 2025 earnings call, 2026-02-04 — Core EPS Q4 $0.50 / FY $2.01. Total new commitments record $15.8B in 2025. Portfolio at fair value ended Q4 at $29.5B. Core EPS fully covered dividends + ROE >10% for both Q4 + FY. Rebound in transaction activity H2 2025 led to meaningful acceleration in new investment commitments. Specialized industry verticals (sports media, specialty healthcare, others) saw non-sponsored originations grow >50%. Portfolio companies: weighted average organic EBITDA growth over 3 times GDP; average portfolio leverage decreased; interest coverage ratio improved to 2.2 times. Credit quality stable with non-accruals in line with prior levels. Pretax net realized gains on investments >$100M FY25. FY26: ~$0.10/share earnings headwind from base rate decline; Q1 2026 dividend $0.48/share payable March 31; strong start with $1.4B+ commitments through January 29, 2026; backlog $2.2B (+17% vs prior); confidence in maintaining dividend with spillover income cushion + low balance sheet leverage + incremental growth opportunities.
• ARCC Q3 / Q2 / Q1 2025 earnings calls — supporting commitments + portfolio + credit quality + dividend coverage trajectory.
• Internal financial_statements view (consolidated annual + cash flow + capital structure).